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OBJECTIVE — Understandingtherelationshipbetweenmultivitaminuseanddiabetesriskis
important given the wide use of multivitamin supplements among U.S. adults.
RESEARCH DESIGN AND METHODS — We prospectively examined supplemental
use of multivitamins and individual vitamins and minerals assessed in 1995–1996 in relation to
self-reported diabetes diagnosed after 2000 among 232,007 participants in the National Insti-
tutes of Health–American Association of Retired Persons Diet and Health Study. Multivitamin
use was assessed by a food-frequency questionnaire at baseline. Odds ratios (ORs) and 95% CIs
were calculated by logistic regression models, adjusted for potential confounders. In total,
14,130 cases of diabetes diagnosed after 2000 were included in the analysis.
RESULTS — Frequent use of any multivitamins was not associated with risk of diabetes after
adjustment for potential confounders and uses of individual supplements. Compared with
nonusersofanymultivitamins,themultivariateORsamonguserswere1.07(95%CI0.94–1.21)
for taking vitamins less than once per week, 0.97 (0.88–1.06) for one to three times per week,
0.92 (0.84–1.00) for four to six times per week, and 1.02 (0.98–1.06) for seven or more times
per week (P for trend  0.64). Signiﬁcantly lower risk of diabetes was associated with the use of
vitamin C or calcium supplements. The multivariate ORs comparing daily users with nonusers
were 0.91 (0.86–0.97) for vitamin C supplements and 0.85 (0.80–0.90) for calcium supple-
ments. Use of vitamin E or other individual vitamin and mineral supplements were not associ-
ated with diabetes risk.
CONCLUSIONS — In this large cohort of U.S. older adults, multivitamin use was not
associatedwithdiabetesrisk.Theﬁndingsoflowerdiabetesriskamongfrequentusersofvitamin
C or calcium supplements warrant further evaluations.
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M
ultivitamin supplements contain
large amounts of many vitamins
and minerals that approximate or
exceed the recommended micronutrient
intakes. With the relative safety and inex-
pensiveness, multivitamins are the most
commonly used dietary supplements in
theU.S.andareadvocatedasanattractive
option for preventing chronic diseases,
such as cancer, cardiovascular disease,
and type 2 diabetes (1,2). Approximately
50% of U.S. adults routinely take multi-
vitamins and spend $23 billion annu-
ally (1).
Type 2 diabetes is considered to be
the epidemic of the 21st century, and its
prevalence in the U.S. is growing rapidly
(3).Giventherisinghealthburdenoftype
2diabetesanditscomplications,thereisa
great urgency to develop effective strate-
gies for curbing this trend. Dietary sup-
plements such as multivitamins have
been commonly used for disease preven-
tion. Evidence from basic research and
observational studies has suggested that
adequate intake of antioxidant vitamins
ormineralsmayprotectagainstthedevel-
opmentoftype2diabetesviareductionof
oxidative stress and its associated meta-
bolic abnormalities, including systemic
inﬂammation, endothelial dysfunction,
hypertension,anddyslipidemia(1,2,4,5).
These metabolic abnormalities act indi-
vidually or synergistically to impair pan-
creatic -cell insulin secretion and
interfere with glucose disposal in periph-
eral tissues (6) and thereby accelerate the
development and progression of both
atherosclerosis and type 2 diabetes. How-
ever, available epidemiological data on
micronutrients and diabetes that focused
on individual vitamin/antioxidant sup-
plements have yielded inconsistent
results.
With their popularity, multivitamin
supplement use contributes to a consid-
erable proportion of micronutrient intake
among users and sometimes excessive in-
takes of certain micronutrients in some
subgroups of the population (2). There is
a longstanding interest in the diabetes re-
search community regarding the poten-
tial, yet unproven, beneﬁts or risks of
multivitaminuseonthedevelopmentand
progression of type 2 diabetes. We there-
fore prospectively evaluate the associa-
tion between the use of multivitamins or
individual micronutrient supplements
anddiabetesriskinalargecohortofolder
adults in the National Institutes of
Health–American Association of Retired
Persons (NIH-AARP) Diet and Health
Study.
RESEARCH DESIGN AND
METHODS— The NIH-AARP cohort
was established in 1995–1996 by the Na-
tional Cancer Institute to investigate the
roles of diet and lifestyle in cancer etiol-
ogy (7). Cohort participants included
566,402 AARP members aged 50–71
years in 1995–1996 from six states (Cali-
fornia, Florida, North Carolina, Pennsyl-
vania, New Jersey, and Louisiana) and
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
From the
1Division of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School,
Boston, Massachusetts; the
2Department of Epidemiology and Health Statistics, Institute of Basic Medical
Sciences, Chinese Academy of Medical Sciences, Beijing, China; the
3Epidemiology Branch, National
Institute of Environmental Health Sciences, Research Triangle Park, North Carolina; the
4Nutritional
Epidemiology Branch, National Cancer Institute, Rockville, Maryland; and the
5American Association of
Retired Persons, Washington, D.C.
Corresponding author: Honglei Chen, chenh2@niehs.nih.gov.
Received 2 July 2010 and accepted 11 October 2010. Published ahead of print at http://care.
diabetesjournals.org on 26 October 2010. DOI: 10.2337/dc10-1260.
© 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Epidemiology/Health Services Research
ORIGINAL ARTICLE
108 DIABETES CARE, VOLUME 34, NUMBER 1, JANUARY 2011 care.diabetesjournals.orgtwo metropolitan areas (Atlanta and De-
troit). All study participants completed a
comprehensive dietary survey that in-
cluded a 124-item food-frequency ques-
tionnaire and a short survey on
demographics, medications, and lifestyle
(7). A follow-up questionnaire was
mailedouttosurvivingparticipantsofthe
original cohort in 2004–2006 to update
exposures and to ascertain the occur-
rences of major chronic diseases, includ-
ing diabetes. A total of 318,261
participants responded to the follow-up
survey and were therefore eligible for the
present study. We excluded 21,632 par-
ticipantswhoprovidednoorinconsistent
information on multivitamin use and
31,383 participants with missing values
on diabetes diagnosis. Because vitamin
supplement use was assessed in 1995–
1996,toreducethepossibilitythatdiabe-
tes itself might have affected health
behaviors, we further excluded 33,239
diabetic patients who reported a diabetes
diagnosis before 2000. Therefore, the ﬁ-
nal analytic sample included 232,007
participants, 217,877 without diabetes
and 14,130 diabetic case subjects diag-
nosed after 2000.
Assessment of vitamin supplement
use
Aspartofthebaselinedietarysurvey,par-
ticipants were asked whether they took
any vitamins or minerals in the past 12
months with three categorical choices
(no, less than once per month, and once
or more per month). For those who took
vitaminsonceormorepermonth,wefur-
ther asked for the frequencies of use for
three types of multivitamins (stress-tab
type, therapeutic or theragran type, and
one-a-day type). Five categorical answers
were allowed for each of these multivita-
mins (times/week): never, less than one,
one to three, four to six, and daily. In ad-
dition to multivitamins, we also asked for
the use of vitamin A, -carotene, vitamin
C, vitamin E, and calcium (including
Tums) with the same categorical frequen-
cies. Finally, participants were asked
whether they took several other individ-
ualvitaminsandmineralsmorethanonce
per month, including iron, zinc, sele-
nium, and folic acid. For individual vita-
mins and minerals, we instructed
participants not to include vitamins and
minerals contained in multivitamins that
they had reported in the multivitamin
section.
In addition, the baseline survey also
collecteddataonbasicdemographicsand
lifestyle such as date of birth, sex, race,
education level, marital status, smoking
habit,andphysicalactivity.Consumption
of coffee and alcohol and dietary intakes
of calories and micronutrients were de-
rived from the food-frequency question-
naire. Finally, participants were asked to
self-evaluate their health status as excel-
lent, very good, good, fair, or poor and to
report weight in pounds (0.45 kg) and
height in inches (2.54 cm). BMI was cal-
culated as weight in kilograms divided by
the square of height in meters (kg/m
2).
Ascertainment of diabetes
A question on lifetime occurrence of phy-
sician-diagnosed diabetes was ﬁrst asked
at the dietary survey in 1995–1996. This
information was updated on the fol-
low-up questionnaire in 2004–2006,
alongwiththeyearofﬁrstdiagnosisinthe
following categories: before 1985, 1985–
1994, 1995–1999, or 2000 to present.
These questions did not differentiate type
2 from type 1 diabetes; however, in
adults, 90–95% of all diagnosed diabe-
tes is type 2 diabetes. Because the current
study included only older adults and
adults with incident cases of diabetes di-
agnosed after 2000, we believe that most
of diabetes cases in the current analysis
should be type 2 diabetes.
Statistical analysis
To minimize the possibility that diabetic
patients modiﬁed their lifestyle around or
after the diagnosis, the current analysis
only included incident diabetes cases di-
agnosed after 2000, at least 4–5 years af-
ter the exposure assessment. The
frequency for overall multivitamin use
was calculated by adding up the use of
individual types of multivitamins. In the
analysis,thefrequencyofsupplementuse
was deﬁned as (times/week) never, less
than one, one to three, four to six, and
daily. No frequency data were collected
for supplemental uses of iron, zinc, sele-
nium, and folic acid, and, thus, only
yes/no variables were included in the
analysis. We performed t tests or ANOVA
for continuous covariates and 
2 tests for
categorical covariates to formally test the
differences of covariates between nonus-
ers and all users as well as among four
categories of users only. Multivariate odd
ratios (ORs) and 95% CIs were derived
from logistic regression models. Potential
confounders included age in year, sex,
race (whites versus nonwhites), educa-
tion level (8 years, 8–11 years, 12 years
or completed high school, post–high
school or some college, college and post-
graduate), marital status (married or liv-
ing as married, widowed, divorced,
separated, or never married), smoking
status (never smokers; past smokers with
years since last smoking: 35, 30–34,
20–29, 10–19, or 1–9; or current smok-
ers with the numbers of cigarettes/day:
1–10, 11–20, or 20), coffee consump-
tion (cups/day: none, less than one, one,
two to three, or more than three), alcohol
consumption (drinks/day: 0, 1, 1–1.9,
2–2.9, or 3), general health status (ex-
cellent, very good, good, fair, or poor),
BMI (in kg/m
2: 12.0–24.9, 25.0–29.9, or
30.0), physical activity (never/rarely,
one to three times per month, one to two
times per week, three to four times per
week, and ﬁve or more times per week),
and total energy intake (quintiles). Multi-
vitamin users were also likely to use indi-
vidual vitamin supplements, and
considerable amounts of micronutrients
form individual supplements may affect
our primary analyses on multivitamin
use.Wethereforeconductedfurtheranal-
ysisadjustingforthesupplementalusesof
individual vitamins and minerals. The
statistical signiﬁcance for a linear trend
was tested by assigning a value to each
exposurecategory(0fornonusers,0.5for
less than one time per week, two for one
tothreetimesperweek,ﬁveforfourtosix
times per week, and seven for daily users)
and including it as a continuous variable
inthelogisticregressionmodel.Theanal-
ysis was ﬁrst conducted for all study par-
ticipants and then stratiﬁed by age (years:
60, 60–64, and 65), sex (men versus
women), general health status (excellent
or very good, good, and fair or poor),
smoking status (never versus ever), BMI
(in kg/m
2: 12.0–24.9, 25.0–29.9, or
30.0), and physical activity (never/
rarely,morethanoncepermonth).When
possible, detailed values of the stratifying
variables were adjusted along with all
other confounders to minimize the possi-
bility of residual confounding.
Ourprimaryanalysisfocusedonmul-
tivitamin supplements. However, we also
examined the use of individual vitamins
andmineralsinrelationtodiabetes.These
analyses showed that vitamin C and cal-
ciumsupplement use was associated with
a lower risk of diabetes. Therefore, we
conducted post hoc analysis to examine
whether these associations were modiﬁed
by the use of multivitamins (users versus
nonusers) or dietary intakes of corre-
sponding nutrients from foods (above
versus below medians). All statistical
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lease 9.1 (SAS Institute, Cary, NC), and
the signiﬁcance tests were two tailed with
0.05.
RESULTS— Of 232,007 participants
(135,423 men and 96,584 women),
72,577(53.6%)menand62,296(64.5%)
women took multivitamin supplements.
Among them, 57,119 (78.7%) men and
48,853 (78.4%) women reported daily
use. Of individual micronutrient supple-
ments, vitamin C (34.6%) was the most
commonly used, followed by vitamin E
(31.6%), calcium (29.4%), -carotene
(13.1%), zinc (10.5%), vitamin A
(10.3%), iron (7.62%), folic acid
(6.54%), and selenium (6.25%).
Table 1 summarizes baseline charac-
teristics according to frequency of multi-
vitamin use. Compared with nonusers of
Table 1—Population characteristics according to baseline multivitamin use in the NIH-AARP Diet and Health Study













n 97,134 4,584 10,729 13,588 105,972
Age (years) 61.3  5.4 60.2  5.3 60.4  5.4 60.4  5.3 61.4  5.4 0.0001
Men (%) 64.7 53.7 53.0 53.8 53.9 0.34
Whites (%) 93.3 92.1 91.8 92.7 94.1 0.0001
BMI (kg/m
2) 26.8  4.7 26.5  4.6 26.6  4.8 26.5  4.5 26.3  4.7 0.0001
High school education or more (%) 75.6 80.5 80.2 81.4 78.8 0.0001
Married or couples 74.2 69.1 67.6 67.4 67.6 0.34
Physical activity (%) 0.0001
Never/rarely 16.5 14.8 14.5 12.4 13.2
One to three times per month 14.2 17.7 16.1 15.0 12.1
One to two times per week 22.1 25.8 26.1 25.9 21.2
Three to four times per week 26.8 26.5 28.0 29.8 30.1
Five or more times per week 19.7 14.7 14.7 16.3 22.9
Smoking (%) 0.0001
Never 38.0 40.6 41.1 40.4 39.0
Past smokers 50.3 46.7 46.4 48.6 51.1
Current smokers 10.5 11.7 11.4 9.9 8.9
Coffee consumption(%) 0.0001
Nondrinker 10.4 9.3 9.2 9.3 10.8
Less than one cup per day 15.3 16.7 16.9 17.2 16.8
One cup per day 15.8 14.3 15.0 14.4 16.2
Two or more cups per day 58.1 59.5 58.7 58.9 55.9
Alcohol consumption (%) 0.0001
Nondrinkers 20.5 18.9 17.2 17.4 20.2
Less than 1 drink per day 14.7 16.4 16.2 15.2 15.6
One or more drinks per day 53.1 55.3 57.2 57.3 54.0
Health status (%) 0.0001
Excellent or very good 59.9 58.8 58.4 60.6 60.6
Good 31.6 32.2 33.3 31.8 31.1
Fair or poor 7.4 7.9 7.2 6.4 7.1
Calorie intake (kcal) 1,835  650 1,797  641 1,805  640 1,786  625 1,798  631 0.15
Single supplement use (%)
Iron 4.1 10.6 12.7 12.8 13.3 0.0001
Zinc 7.2 13.5 14.7 16.5 18.7 0.0001
Selenium 4.2 5.8 6.9 8.8 11.6 0.0001
Folate 4.6 7.7 8.4 9.7 11.9 0.0001
Vitamin A‡ 5.9 16.1 17.4 17.8 17.9 0.005
-Carotene‡ 8.8 18.2 18.9 21.1 23.2 0.0001
Vitamin C‡ 22.5 57.7 55.3 57.6 60.2 0.0001
Vitamin E‡ 22.3 44.8 46.9 50.9 55.9 0.0001
Calcium‡ 16.7 48.2 48.1 49.7 51.1 0.0001
Data are means  SD for continuous variables and proportions for categorical variables. The numbers of missing observations are 2,076 (0.89%) for race, 4,063
(1.75%) for BMI, 4,688 (2.02%) for education, 1,176 (0.51%) for marriage, 1,505 (0.65%) for physical activity, 2,605 (1.12%) for smoking, 750 (0.32%) for coffee
consumption, 25,062 (10.80%) for alcohol consumption, 2,753 (1.19%) for health status, 13,954 (6.01%) for calorie intake, and 0.2% for individual vitamin
supplements. *All P values 0.0001 for differences of covariates between never users and all users, with the exception of health status (P  0.017). †P values for
theglobaldifferencesofcovariatesacrossfourfrequencycategoriesofmultivitaminusersonly.‡Combinedfourfrequenciesofsupplementuse(times/week:lessthan
one, one to three, four to six, and daily) as yes.
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tendedtohaveaslightlyhealthierlifestyle
than nonusers. Users were more likely
than nonusers to be women, white,
slightlylean,physicallyactive,drinkalco-
hol, and be graduates with a high school
degree or higher but less likely to be cur-
rent smokers (all P  0.0001). They were
also more likely to report the use of indi-
vidual supplements of vitamins and min-
erals than those who did not use
multivitamins. Multivitamin users re-
ported slightly healthier health status
than nonusers at baseline (P  0.017).
The distributions of covariates across
multivitamin use frequencies appeared to
be more complex; for most covariates, no
apparent monotonic trends were ob-
served across frequencies of multivitamin
use.
Baseline use of multivitamins in
1996–1997 was examined in relation to
incidentdiabetes(n14,130)diagnosed
after 2000 (Table 2). Compared with
nonusers of multivitamin supplements,
the multivariate-adjusted ORs after con-
trolling for traditional diabetes risk fac-
tors were 1.03 (95% CI 0.91–1.17) for
less than one time per week, 0.93 (0.85–
1.01) for one to three times per week,
0.85(0.78–0.92)forfourtosixtimesper
week, and 0.96 (0.92–0.99) for seven or
more times per week (P for trend 
0.008). However, this signiﬁcant associa-
tion disappeared after further adjusting
for use of individual micronutrient sup-
plements (P for trend  0.64). Similarly,
none of the individual types of multivita-
mins (one-a-day, theragran, and stress
tab) were associated with diabetes risk,
aftercontrollingforusesofindividualmi-
cronutrientsupplements.Wefurtherper-
formed several subgroup analyses by age,
sex, self-assessed health status, smoking
status,BMI,andphysicalactivitytoexam-
ine whether multivitamin use was associ-
ated with diabetes risk in any of these
subpopulations (supplementary Table A1 in
the online appendix, available at http://
care.diabetesjournals.org/cgi/content/full/
dc10-1260/DC1). No signiﬁcant associations
were observed.
In the analysis of individual vitamins
and minerals (Table 3), we found statisti-
cally signiﬁcant associations between the
use of vitamin C or calcium and a lower
risk of diabetes. Compared with nonus-
ers, the multivariate-adjusted ORs of dia-
betesriskamongdailyuserswere0.91for
vitamin C (95% CI 0.86–0.97; P for
trend  0.001) and 0.85 for calcium
(0.80–0.90; P for trend 0.0001). Fur-
ther analysis suggests that the association
between vitamin C supplement use and
diabetes risk may be limited to individu-
als who did not use multivitamins or had
low dietary intake of vitamin C (supple-
mentary Table A2). In contrast, the in-
verse association between frequent use of
calcium and diabetes risk did not vary by
multivitamin use or dietary intake of cal-
cium or vitamin D. As calcium intake
might likely be used by participants with
low body weight for bone health who
might also have a lower risk of diabetes,
we further controlled in the analysis for
weight change between baseline and the
follow-up survey. The results were barely
changed (data not shown). Finally, we
found total calcium intake was also asso-
ciated with lower diabetes risk, but this
association appeared to be driven by cal-
ciumsupplementsratherthancalciumin-
take from dietary sources (data not
shown).
CONCLUSIONS — In this large co-
hort of older adults, we did not ﬁnd an
associationbetweenmultivitaminuseand
future diabetes risk. Our data, however,
suggest a lower risk of diabetes among
regularusersofvitaminCorcalciumsup-
plements. Because of the exploratory and
observational nature of our study, poten-
tial beneﬁt of vitamin C and calcium use
on diabetes prevention should be further
evaluated.
Multivitaminsarewidelyusedamong
U.S. adults, particularly the elderly, for
potential health beneﬁts. To the best of
our knowledge, our study is the ﬁrst pro-
spective evaluation on potential beneﬁts
Table 2—ORs (95% CI) of diabetes risk according to baseline use of multivitamin in the NIH-AARP Diet and Health Study












n cases 6,483 291 626 699 6,031
OR (95% CI)* 1.00 1.03 (0.91–1.17) 0.93 (0.85–1.01) 0.85 (0.78–0.92) 0.96 (0.92–0.99) 0.008
OR (95% CI)† 1.00 1.07 (0.94–1.21) 0.97 (0.88–1.06) 0.92 (0.84–1.00) 1.02 (0.98–1.06) 0.64
Individual multivitamin
Stress-tab type
n cases 12,996 119 121 97 559
OR (95% CI)* 1.00 1.02 (0.84–1.24) 1.04 (0.86–1.25) 1.07 (0.87–1.33) 0.96 (0.88–1.05) 0.52
OR (95% CI)† 1.00 1.06 (0.87–1.28) 1.08 (0.89–1.31) 1.18 (0.95–1.46) 0.99 (0.90–1.09) 0.79
Therapeutic or theragran type
n cases 12,131 102 144 158 1,376
OR (95% CI)* 1.00 0.94 (0.77–1.15) 0.88 (0.74–1.04) 0.96 (0.82–1.14) 1.00 (0.95–1.06) 0.91
OR (95% CI)† 1.00 0.96 (0.78–1.18) 0.91 (0.76–1.08) 1.04 (0.88–1.23) 1.04 (0.98–1.11) 0.17
One-a-day type
n cases 8,022 260 494 561 4,677
OR (95% CI)* 1.00 0.97 (0.85–1.11) 0.92 (0.84–1.02) 0.84 (0.77–0.92) 0.96 (0.92–0.99) 0.006
OR (95% CI)† 1.00 0.99 (0.87–1.13) 0.94 (0.85–1.04) 0.90 (0.82–0.99) 1.00 (0.96–1.04) 0.63
*Adjustedforage,sex,race,BMI,educationlevels,maritalstatus,physicalactivity,smokingstatus,coffeeconsumption,alcoholconsumption,generalhealthstatus,
and total energy intake. †Further adjusted for uses of individual vitamins and minerals: yes/no: iron, zinc, selenium, and folate; frequency (never, less than one, one
to three, four to six, and seven times per week): vitamin A, -carotene, vitamin C, vitamin E, and calcium.
Song and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 34, NUMBER 1, JANUARY 2011 111and risks of multivitamin use in prevent-
ing type 2 diabetes. There are several ex-
planationsforthenullassociation.First,it
is likely that multivitamins at their cur-
rent composition cannot reduce the risk
of diabetes. Most multivitamins contain
loweramountsofsingleantioxidantsthan
individual vitamin supplements and thus
might not be sufﬁcient to be biologically
effective. Alternatively, as multivitamins
contain many vitamins and minerals, it is
possiblethatthepotentialmildbeneﬁtsof
some micronutrients are antagonized by
detrimental effects from others.
Associations between intakes or bi-
omarkers of vitamins and minerals and
diabetesriskhavebeenexaminedinsome
epidemiologicalstudies.Forexample,ob-
servational studies have found signiﬁcant
inverse correlations between antioxidant
levels and several biomarkers of insulin
resistance and/or glucose intolerance in
healthy individuals (8). Antioxidant lev-
els in the blood, such as vitamins C and E
and -carotene, were also signiﬁcantly
lower in individuals with type 2 diabetes
than in nondiabetic control subjects
(9,10). Previous prospective cohort stud-
ies consistently reported an inverse asso-
ciation between incidence of type 2
diabetes and dietary, serum, or plasma
levels of vitamins C (11) and E (11–13)
and -carotene (11,14) among initially
nondiabetic individuals. However, there
have been few clinical trials on vitamin
supplements for primary prevention of
type 2 diabetes. Secondary analyses of
randomizedclinicaltrialsoncardiovascu-
lar events and cancers found no signiﬁ-
cant effects of vitamin E or -carotene
supplementation on the incidence of type
2 diabetes (15,16). Further, one trial (17)
reportednoeffectofhomocysteinelower-
ing by B vitamin supplements on the risk
ofdevelopingtype2diabetes.Finally,ep-
idemiological studies (18,19) yielded in-
consistent evidence on other individual
micronutrient supplements (such as zinc,
chromium, and selenium) and type 2 di-
abetes in adults.
Despite the lack of beneﬁt of multivi-
taminsondiabetesrisk,wefoundthatus-
ers of either vitamin C or calcium had a
lower risk of diabetes than nonusers. The
potential beneﬁt of a vitamin C supple-
ment seem to be limited to individuals
who did not take multivitamins or had
lower dietary intake of vitamin C, which
isconsistentwithsomeevidencethatsug-
geststhatdietaryvitaminCintakemaybe




n cases 12,836 1,294
OR (95% CI) 1.00 1.02 (0.95–1.09) 0.64
Zinc
n cases 12,359 1,771
OR (95% CI) 1.00 1.05 (0.98–1.13) 0.16
Selenium
n cases 13,158 972
OR (95% CI) 1.00 0.94 (0.86–1.03) 0.18
Folate
n cases 13,012 1,118
OR (95% CI) 1.00 1.02 (0.95–1.11) 0.56












n cases 12,384 266 216 145 1,106
OR (95% CI) 1.00 1.15 (0.99–1.34) 1.07 (0.91–1.26) 1.05 (0.86–1.29) 1.08 (1.00–1.18) 0.061
-carotene
n cases 12,003 239 281 205 1,390
OR (95% CI) 1.00 0.96 (0.82–1.12) 1.11 (0.96–1.28) 1.01 (0.85–1.20) 1.05 (0.97–1.14) 0.17
Vitamin C
n cases 8,762 638 559 450 3,700
OR (95% CI) 1.00 0.95 (0.86–1.04) 0.97 (0.87–1.08) 0.89 (0.78–1.00) 0.91 (0.86–0.97) 0.0012
Vitamin E
n cases 9,045 364 441 446 3,818
OR (95% CI) 1.00 0.99 (0.87–1.13) 0.90 (0.80–1.02) 0.91 (0.80–1.03) 0.99 (0.93–1.04) 0.51
Calcium
n cases 9,972 644 599 412 2,486
OR (95% CI) 1.00 0.92 (0.84–1.01) 0.91 (0.83–1.00) 0.85 (0.76–0.95) 0.85 (0.80–0.90) 0.0001
*Adjustedforage,sex,race,BMI,educationlevels,maritalstatus,physicalactivity,smokingstatus,coffeeconsumption,alcoholconsumption,generalhealthstatus,
totalenergyintake,anymultivitaminuse,andindividualvitaminsandmineralsyes/no:iron,zinc,selenium,andfolate;frequency(never,lessthanone,onetothree,
four to six, and seven times per week): vitamin A, -carotene, vitamin C, vitamin E, and calcium, when possible.
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tion, especially among the elderly (20).
Vitamin C is a potent water-soluble anti-
oxidant and can effectively scavenge sev-
eral reactive species and regenerate
tocopherolsandtocotrenolsfromtheirre-
spective radical species (20). Vitamin C
may also have a role in the energy-
dependentreleaseofinsulinfrompancre-
aticislets(21).Somesmallandshort-term
randomized trials have been conducted
among patients with type 2 diabetes;
somereportedthatvitaminCsupplemen-
tation (1–2 g/day) reduced oxidative
stress and improved endothelial function
indiabeticpatients(20).Further,arecent
trial has shown suggestive evidence for
vitamin C (500 mg/day) in preventing
type2diabetesamongwomenathighrisk
of cardiovascular disease (16). Because of
limited data from randomized trials, our
observational evidence of a potential ben-
eﬁt of vitamin C supplementation in dia-
betes prevention should serve as a
stimulus for further investigation.
We found a consistent association of
calcium supplementation with lower dia-
betes risk. It is difﬁcult to argue that such
residual confounding was speciﬁc to cal-
cium but not to multivitamins or other
micronutrient supplements. On the other
hand, it is plausible that a potential ben-
eﬁcial effect of calcium on diabetes is par-
tially mediated by its effects on blood
pressure(22),insulinsensitivity(23),and
body weight (24). Recently, animal and
human studies indicated that high cal-
ciumintakemightdecreaselevelsofpara-
thyroid hormone and 1,25(OH)2 vitamin
D (calcitriol) and thus inﬂuence adipo-
cyte metabolism by inhibiting lipogenesis
and stimulating lipolysis (25). Moreover,
the biological effects of calcium may well
depend on the presence or absence of
other highly correlated nutrients, espe-
ciallyvitaminD.Ourresultsdidnotshow
thatdietaryvitaminDintakemodiﬁedthe
association between calcium supplement
use and type 2 diabetes. Because of the
lackofinformationonvitaminDcontents
in multivitamin supplements and the rel-
atively low proportions of vitamin D sup-
plement use, we cannot address the
comparative importance of calcium and
vitamin D in the observed associations.
Further, we found no evidence for the as-
sociation between calcium intake from
diet alone and diabetes risk. Therefore,
we cannot entirely exclude the possibility
thattheassociationbetweencalciumsup-
plement use and diabetes could be ex-
plained by unmeasured confounding.
Major strengths of the current study
include its large sample size, prospective
study design, detailed measures of epide-
miologicproﬁles,andthoroughstatistical
analyses. Our study also has several limi-
tations. First, in such a large cohort, we
had to rely on self-reported diagnoses
rather than annual glucose tolerance
screening to identify diabetic patients. If
participants with undiagnosed diabetes
orprediabeticstatususedvitaminsupple-
ments more or less frequently than did
truly healthy participants, the risk esti-
mates might have been biased. To mini-
mize this possibility, we only included
diabetescasesdiagnosedafter2000inthe
current analyses. Second, information on
vitamin/mineral supplement use was self-
reported and therefore misclassiﬁcations
are likely. The exposure misclassiﬁcation
was likely nondifferential with respect to
the outcome and might thus have attenu-
ated the true relationships. Third, we did
not collect data on the duration of multi-
vitamin use and the frequency over the
follow-up period to account for time-
varying effects. Finally, although we have
controlledforandstratiﬁedbyavarietyof
potential confounders, the study is obser-
vational in nature and we could not ex-
clude the possibility of chance or residual
confounding from unmeasured or inade-
quately measured confounders.
In conclusion, this large prospective
study among U.S. older adults provides
evidence against use of multivitamin sup-
plements for diabetes prevention. Our
preliminary ﬁndings on lower diabetes
risk among users of vitamin C and cal-
cium supplements are intriguing and
should be followed-up in future
investigations.
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